Senyo Health App - Connecting Primary Care to Substance Use Disorder Treatment Using a Telehealth Collaborative Care Platform
Overview
- Phase
- Not Applicable
- Status
- Enrolling By Invitation
- Sponsor
- Mayo Clinic
- Enrollment
- 60
- Locations
- 2
- Primary Endpoint
- Brief Substance Craving Scale (BSCS)
Overview
Brief Summary
The purpose of this study is to examine the barriers, facilitators, and optimal processes for implementing a digitally enhanced screening, brief intervention, and referral to treatment (SBIRT) model for Substance Use Disorder SUD treatment among Mayo primary care clinics.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Ability to read, write, and understand English
- •Minimum DAST (1+), audit-C score (3+)
- •Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care.
- •Access to or willingness to obtain a Primary care provider at a participating Mayo Clinic site;
- •Eligibility determined by ASAM Assessment
Exclusion Criteria
- •Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis
- •Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment
- •Needing a higher level of mental health care as demonstrated by ASAM32 assessment.
- •Decline to answer suicidality questions.
- •Already admitted into or about to initiate treatment in another addiction treatment program.
- •Currently attending High School.
Arms & Interventions
Senyo
Subjects to the Senyo group will begin receiving intervention immediately, and will move to the follow-up phase after 12 weeks.
Intervention: Senyo App (Behavioral)
Senyo
Subjects to the Senyo group will begin receiving intervention immediately, and will move to the follow-up phase after 12 weeks.
Intervention: Follow-up (Behavioral)
Outcomes
Primary Outcomes
Brief Substance Craving Scale (BSCS)
Time Frame: Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months
The Brief Substance Craving Scale is a 16 item, self-report instrument that assesses craving for substances of abuse over a 24 hour period. Intensity and frequency of craving are recorded on a five-point Likert scale, with 0 = Not at all, 1 = Slight, 2 = Moderate, 3 = Considerable, and 4 = Extreme.
Timeline Follow Back
Time Frame: Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months
Timeline Follow Back is an assessment to document substance use over a specific period of time
Secondary Outcomes
- Generalized Anxiety Disorder-7 (GAD-7)(Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months)
- Patient Health Questionnaire-9 (PHQ-9)(Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months)
Investigators
Tyler S. Oesterle
Principal Investigator
Mayo Clinic